Understanding and managing risk is essential for medical device innovation and patient safety. This whitepaper explores why benefit-risk analysis is not only a regulatory requirement but also a vital process for ensuring that medical devices provide significant clinical benefits while minimizing potential harms. Based on the latest EU MDR guidelines and ISO standards, it illustrates how thorough, evidence-based assessments support market approval and ongoing clinical decision-making.
The paper presents practical frameworks for evaluating both the clinical benefits and risks, incorporating both qualitative and quantitative approaches. It outlines how to systematically evaluate the magnitude, probability and duration of benefits against the severity and likelihood of risks, utilizing real-world data and advanced benchmarks. Examples and visual aids guide the calculation of benefit and risk values, as well as the interpretation of benefit-risk ratios and criteria for determining acceptability, in line with global best practices.
This resource helps manufacturers, clinicians and regulatory professionals navigate the complexities of benefit-risk analysis throughout the device lifecycle.
Download the whitepaper for actionable insights that enhance compliance, support safer product development and improve patient outcomes in the evolving field of medical devices.
